Biomarker Study Finds Levels of Novel Cytokine Highly Correlated To COVID-19 Severity and Mortality
A new COVID-19 acute respiratory distress syndrome (ARDS) biomarker study has found that that levels of novel cytokine, LIGHT, were highly correlated with disease severity and mortality. More...03 Jun 2020
Mobidiag PCR and Antibody Tests Offer Comprehensive Diagnostic Solution for Detection of Coronavirus
Mobidiag Ltd. (Espoo, Finland) has received CE-IVD markings for its Novodiag COVID-19 and Amplidiag COVID-19 molecular diagnostic tests for the early detection of the SARS-CoV-2 virus. More...03 Jun 2020
Siemens Granted FDA Emergency Use Authorization for SARS-CoV-2 Total Antibody Test
Siemens Healthineers (Erlangen, Germany) has secured Emergency Use Authorization from the US Food and Drug Administration for its laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies, including IgM and IgG in blood. More...02 Jun 2020
Gilead’s Phase 3 Trial of Remdesivir Demonstrates Significantly Greater Clinical Improvement in Patients with Moderate COVID-19
Gilead Sciences, Inc. (Foster City, CA, USA) has announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. More...02 Jun 2020
Longhorn Vaccines and Cenetron Diagnostics Join Coca-Cola Bottlers to Produce COVID-19 Test Kits
Longhorn Vaccines and Diagnostics LLC (Bethesda, MD, USA) and Cenetron Diagnostics (Austin, TX, USA) have collaborated with Southeastern Container (SEC) to expand production of COVID-19 testing kits. More...02 Jun 2020
In Other News
Eli Lilly and AbCellera Begin World's First Study of Potential COVID-19 Antibody Treatment in Humans
Celltrion’s COVID- 19 Antiviral Antibody Treatment Shows Improved Recovery Time in Pre-Clinical Study
COVID-19 Vaccine Likely to Be Ready by October This Year, Says Pfizer CEO
New Technology Solutions Use Real Time, Scientific, and Geocoded Data to `Flatten the COVID-19 Curve`
Moderna Initiates Phase II Study of mRNA Vaccine Against Novel Coronavirus
Chinese Firm Sinovac Biotech Says It Is 99% Sure that Its COVID-19 Vaccine Will Work
EKF Diagnostics Secures Contracts for Manufacture and Supply of Novel, Patented COVID-19 Sample Collection Device
Yale Researchers Use Single-Cell Analysis and Machine Learning to Identify Major COVID-19 Target
Monkeys Demonstrate Immunity Against Novel Coronavirus in New Study
Need for Rapid Containment Measures to Drive Growth of Global COVID-19 Detection Kits Market
Biogen and Vir Biotechnology Partner to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment
Supply Chain Issues Continue to Impact Labs Providing SARS-CoV-2 Testing, Finds AMP Survey
New One-Minute COVID-19 Test Detects Antibodies from Single Drop of Blood
Study Finds Immunity to Coronavirus May Last Only Six Months with Reinfection Possible
HEMCO Corporation’s MicroFlow I Ductless Workstation Ensures Safety Comes First
Air Science’s Purair BIO Biological Safety Cabinet Provides Safe Laboratory Workspace
Sheba Medical Center’s New COVID-19 Inspired Immersive Simulation Patient Room Uses AI, AR and Robotic Monitoring
Universally Effective Antibodies Found in COVID-19 Patients Raise Hopes of Coronavirus Vaccine
Swift Biosciences Launches Normalase Amplicon Panel (SNAP) SARS-CoV-2 Kit
Roche and Gilead Collaborate to Test Actemra-Remdesivir Cocktail in Severe COVID-19 Cases
GSK to Produce One Billion Doses of COVID-19 Vaccine Booster
NIH Launches Global COVID-19 Digital Pathology Repository
Bio-Rad Collaborates with Biodesix to Launch Blood-Based Immunoassay-Based Test to Detect Coronavirus Antibodies